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People with osteoarthritis (OA) can have significant pain that interferes with function and quality of life. Women
with knee OA have greater pain and greater reductions in function and quality of life than men. In many cases, OA
pain is directly related to sensitization and activation of nociceptors in the injured joint and correlates with the
degree of joint effusion and synovial thickening. In some patients, however, the pain does not match the degree of
injury and continues after removal of the nociceptors with a total joint replacement. Growth of new nociceptors,
activation of nociceptors in the subchondral bone exposed after cartilage degradation, and nociceptors innervating
synovium sensitized by inflammatory mediators could all augment the peripheral input to the central nervous
system and result in pain. Enhanced central excitability and reduced central inhibition could lead to prolonged and
enhanced pain that does not directly match the degree of injury. Psychosocial variables can influence pain and
contribute to pain variability. This review explores the neural and psychosocial factors that contribute to knee OA
pain with an emphasis on differences between the sexes and gaps in knowledge.
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Introduction
The International Association for the Study of Pain
(IASP) defines pain as an unpleasant sensory and emo-
tional experience associated with actual or potential tis-
sue damage, or described in terms of such damage. Pain,
therefore, is a subjective experience that not only
involves the sensation itself, but also includes an un-
pleasantness dimension to the experience (see Table 1
for pain terminology). The pain associated with osteo-
arthritis (OA) can limit function and reduce quality of
life. Although OA pain may appear to reflect activation
of nociceptors in the damaged joint in some cases, what
determines the actual perception of pain at any time is
how the central nervous system (CNS) uses and modifies
information derived not only from nociceptors but also
from other sources. (The IASP defines a nociceptor as
“A high-threshold sensory receptor of the peripheral* Correspondence: kathleen-sluka@uiowa.edu
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reproduction in any medium, provided the orsomatosensory nervous system that is capable of trans-
ducing and encoding noxious stimuli.”). The mechan-
isms underlying these differences in pain between
women and men with knee OA are unknown. Improving
our understanding of the mechanisms underlying sex
differences in the perception of pain in OA will likely
lead to more effective, and possibly sex-specific, treat-
ment strategies.
Significant clinical differences in pain exist between
men and women with knee osteoarthritis. Women more
commonly have OA of the knee and lose articular cartil-
age from the proximal tibia at four times the annual rate
of men and from the patella at three times a greater rate
[1]. In patients with knee OA who undergo total knee
arthroplasty, women have lower functional scores and
report greater pain than men both before and after total
knee arthroplasty [1]. In a large study of 5290 patients
two years after surgery, 36% more women than men had
moderate to severe pain at 2 years [2]. Even with adjust-
ment for age and preoperative pain level, women were
more likely to have moderate-to-severe pain at 2 years
after arthroplasty.td. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
Table 1 Pain terminology as defined by the International Association for the Study of Pain (www.iasp-pain.org)
Terminology Definition Comments
Nociceptor A sensory receptor that is capable of transducing and
encoding a noxious stimulus
Nociceptors are located in a variety of tissue types including most
structures of the articular joint
Nociceptive
neuron
A central or peripheral neuron that is capable of encoding
noxious stimulation
Sensitization Increased responsiveness of neurons to normal input or
activation of a response by inputs that are normally
subthreshold
Can occur in the periphery (nociceptors) or in the CNS pathway
Primary
hyperalgesia




Increased response to a stimulus that is normally painful Occurs outside the site of insult in tissue that is not injured; results
from central neuron sensitization
Allodynia Pain due to a stimulus that does not normally evoke pain Results from central neuron sensitization
Temporal
Summation
Increased pain to application of the same stimulus
repetitively over a brief period of time





Application of a noxious stimulus distant to the test area
(such as leg) produces analgesia (such as arm)
Decreased in patients with osteoarthritis; surrogate measure of central
inhibition; also referred to as diffuse noxious inhibitory control (DNIC)
Pain
catastrophizing
Tendency to magnify the consequences of the pain and to
feel helpless in managing the pain
Higher levels associated with higher OA pain, and worse outcomes
(disability, pain)
Self-efficacy Lower levels are associated with worse outcomes (function, pain)
Fear of pain/
movement
Excessive expectation that physical activity will worsen pain
and function













Figure 1 Schematic diagram of the interactions between neural
(peripheral and central) and psychosocial factors in the
modulation of osteoarthritic (OA) pain.
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joints hurt? Do women have more pain than men? Do
women have different underlying biological mechanisms
that explain the differences in pain? What is the role of
the nociceptor in the peripheral nervous system and
what is the role of the central nervous system in gener-
ating and maintaining pain? What roles do psychosocial
variables have in the OA pain and sex differences in OA
pain? A schematic diagram representing potential
mechanisms and modulating factors, that is, peripheral
factors, central factors, and psychosocial factors that
contribute to OA pain, is shown in Figure 1. This review
examines the evidence for potential peripheral and cen-
tral neural mechanisms responsible for the pain asso-
ciated with knee OA, and how psychosocial variables
influence the pain. We further identify gaps in research
to further our understanding of sex differences in OA
pain.
Pain perception: an overview
The complexity of pain in OA is highlighted by the lack
of correlation between individual pain and the degree of
radiographic changes [3-5]. Even individuals with no his-
tory of knee pain can exhibit radiographic abnormalities
consistent with early osteoarthritis such as osteophytes
and joint space narrowing, or abnormalities on MRI
such as cartilage damage, bone marrow lesions, osteo-
phytes, synovitis or effusion [3-5]. Conversely, some
individuals with knee pain present with no joint abnor-
malities [4,6]; no differences were observed between thesexes [6]. These inconsistent associations between joint
abnormalities and pain, and the persistent pain that can
continue after total knee replacement, suggest that fac-
tors other than nociceptor activation are involved in
maintaining the pain. It is likely that central sensitization
is responsible for the persistent and elevated pain experi-
enced by individuals in whom the pain is disproportion-
ately greater than the damage in the joint.
Injury to a tissue is often accompanied by plastic
changes in the nervous system that augment the excit-
ability of neurons. Some nociceptive peripheral afferents,
Figure 2 This figure illustrates how the knee can engage the nervous system to give rise to different types of pain associated with
knee OA. Part 1 shows anterior (1A, 1C) and lateral (1B, 1D) views of the healthy (1A, 1B) and OA knee (1C, 1D). Blue lines emerging from the
knee depict nociceptors conveying information from the knee to the CNS (lumbar spinal cord). Green lines depict postganglionic sympathetic
fibers sending efferent information from the CNS to the knee. Only sensory fibers are shown in 1a-d. In the OA knee, sensory and sympathetic
fibers sprout branches into articular cartilage (* in 1C, 1D). Part 2 illustrates the connection between the knee and the spinal cord. Sensitized
afferent fibers can sensitize neurons in the lumbar dorsal horn. This ‘central sensitization’, shown by the red circle in the spinal cord, can become
independent of and is modulated differently from ‘peripheral sensitization’. Part 3: Input from nociceptors to the spinal cord is concentrated in
the segment associated with the body part the nociceptors innervate (lumbar segments). However, branches of nociceptors also extend to other
rostral and caudal segments (blue lines) - normally, nociceptors have minimal impact on neurons in these segments. When nociceptors become
sensitized they increase input to the spinal cord and sensitize central neurons in the innervated and uninnervated segments (green lines; red
asterisks). Part 4: Multiple intersegmental excitatory and inhibitory spinal connections exist to coordinate nociceptive information (double-
arrowed black lines). Central sensitization (red circles) is modulated by this inter-segmental communication. Part 5: Multiple connections exist
that ascend from the spinal cord to the brain (blue lines) and descend from the brain to the spinal cord (green lines). Thus, input from the spinal
cord engages neurons throughout the brain via complex ascending and descending systems. Input from sensitized spinal neurons can influence
activity throughout the neuraxis altering normal processing of nociceptive and non-nociceptive information. Some regions that can be influenced
are depicted by red circle. a, meniscus; b, lateral collateral ligament; c, distal femur; d, medial collateral ligament; e, posterior cruciate ligament; f,
anterior cruciate ligament; g, proximal tibia; h, synovium; i, periosteum; j, joint capsule; k, patella; l, subchondral bone; m, normal articular
cartilage; n, arthritic articular cartilage; o, osteophyte. Figure was adapted from [7].
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and exhibit a greater responsiveness to noxious stimuli
applied to the periphery – termed peripheral sensitization.
Similarly, the properties of neurons throughout the CNS
can also change by increasing spontaneous activity and
responsiveness to peripheral stimuli – termed central
sensitization. Figure 2 shows pathways in the peripheral
and central nervous system that contribute to OA pain.
OA pain is associated with local pain and increased
sensitivity to noxious stimulation of the involved joint
(primary hyperalgesia). The local pain and primary
hyperalgesia are likely due to peripheral sensitization.
People with OA also have 1) pain beyond the involved
limb (referred pain), 2) increased sensitivity to noxious
stimuli beyond the site of injury (secondary hyperalge-
sia), and 3) an increased sensitivity to innocuous stimuli
(allodynia). The referred pain, secondary hyperalgesia,
and allodynia are probably a consequence of central
sensitization.
People with pain, including those with OA, likely have
both peripheral and central sensitization. In some cases,
the pain is directly related to sensitization and activation
of nociceptors in the damaged joint and correlates with
the degree of joint effusion and synovial thickening [8,9].
Significantly decreasing nociceptor activity by perform-
ing joint replacement surgery provides the majority of
patients with a relatively pain-free joint. In some
patients, however, the pain does not match the degree of
joint damage and continues even after total joint re-
placement [10]. It is important to recognize that follow-
ing joint replacement, the capsule, ligamentous
structures, and part of the synovium remain intact, and
thus there is still nociceptor innervation of joint struc-
tures. The occurrence of persistent pain at 3–6 months
after total knee replacement may be as high as 35% [10],
but this percentage decreases to 13% at one year [11]
and 10% at 7 years [12]. None of these studies compared
the differences in pain after total knee replacement be-
tween men and women.
Predictive factors associated with the persistence of
chronic pain after total knee replacement in patients
with OA include high pain ratings prior to surgery, high
pain ratings in the immediate postoperative period, mul-
tiple pain sites, loss of central inhibition preoperatively,
higher pain catastrophizing, and the sex of the individ-
ual, with women at greater risk of chronic pain after sur-
gery including those with total knee replacement or
thoracotomy [2. 12]. Furthermore, the risk of developing
chronic pain after total knee replacement can be corre-
lated to preoperative symptoms of depression and anx-
iety, pain catastrophizing, as well as the presence of
poor coping strategies [13-19].
Differences between men and women with osteo-
arthritis are complicated by the fact that women mayalso be pre- or post-menopausal. Post-menopausal women
may also be undergoing replacement therapy. These
factors are rarely considered in the analysis and deter-
mination of factors that contribute to differences in pain
and function in osteoarthritis. One interesting study
showed no difference in pain or pain thresholds in
post-menopausal women receiving hormone replacement
therapy (n=32), post-menopausal women not receiving
hormone replacement therapy (n=42) and men (n=58)
with osteoarthritis. However, men show a greater preva-
lence of osteoarthritis prior to age 45 and women show
a greater prevalence after age 45 [20]. Together these
data suggest future studies should more closely examine
sex differences across the lifespan, as well as the influ-
ence of hormones on these sex differences.
In summary, multiple factors likely contribute to OA
pain. Changes in nociceptor sensitivity may drive some
of the pain of OA. The increased nociceptor activity can
further drive changes in the central nervous system to
augment and prolong pain independent of the nocicep-
tor activity. Lastly, psychosocial variables can influence
and modulate pain further contributing to the pain
observed in people with OA. How these variables differ
across the sexes, and the gaps in our knowledge related
to sex differences, will be highlighted in the following
sections focusing on 1) peripheral factors, 2) central fac-
tors, and 3) psychosocial factors that contribute to OA
pain.
Peripheral factors contributing to osteoarthritic pain
Nociceptors normally innervate the periosteum, menis-
cus, subchondral bone, synovium, capsule, and ligaments
[21] (human, rat, cat, monkey) and thus information
arising from any of these joint structures could contrib-
ute to the pain associated with OA. The exception is car-
tilage, which is aneural and avascular, although Schwab
and Funk [22] found that branches of some periosteal
nerve fibers penetrated the hyaline articular cartilage in
close proximity with chondrocytes and near to the inser-
tion of tendons and muscles (in rat). Cartilage degrad-
ation is a hallmark of OA, and denuded subchondral
bone resulting from cartilage damage may be responsible
for OA pain during joint movement due to the mechan-
ical activation of nociceptors innervating the subchon-
dral bone. Recent data, for example, show sprouting of
nerve fibers to joint tissues that were previously not
innervated, such as the presence of sympathetic and sen-
sory nerves in vascular channels within the articular car-
tilage. Sprouting of nerve fibers also occurs in the
subchondral bone and in osteophytes [23,24]. Thus, new
nerve growth may result in enhanced activity of nocicep-
tors from injured tissues. It is not yet known if there are
differences in sprouting of nerve fibers between the
sexes that could underlie the sex differences in pain.
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involves synovial inflammation [21]. Increases in neuro-
peptide and ion channels expression in nociceptors in-
nervating the synovium are observed in animal models
associated with synovial inflammation, and in people
with OA [21]. Inflammatory mediators, such as prosta-
glandins and pro-inflammatory cytokines (e.g., IL-6, IL-
1beta, TNF) activate and sensitize nociceptors [25],
which is manifested as increased spontaneous activity of
the nociceptor and increased response to mechanical
stimulation associated with joint movement [21,25].
Few data are available on the influence of sex hor-
mones on innervation patterns or nociceptor activity,
particularly as these factors relate to OA. However, two
studies of the temporomandibular joint (TMJ) suggest
augmented excitability of nociceptors in association with
estrogens. Estradiol increases the excitability of nocicep-
tors innervating the TMJ as evidenced by a decrease in
action potential threshold and an increase in the inci-
dence of spontaneous activity in ovariectomized rats
with estradiol replacement compared with ovariecto-
mized rats without replacement [26]. Further, nocicep-
tors innervating the TMJ of female rats show a greater
response to intraarticular injection of glutamate com-
pared with those from male rats [27]. These data suggest
that nociceptors in females are more excitable and ex-
hibit augmented activity in response to noxious stimuli.
It is unknown at this point if there are changes in noci-
ceptor excitability after menopause when circulating es-
tradiol would decrease, or if these changes persist due to
local sources of estradiol in joint structures (see accom-
panying review by Hart et al. entitled “HormonalTable 2 Peripheral mechanisms of knee OA
Study Male Female Not stated




Flake et al., 2005 [26] Rat
Heppleman, 1997 [21] Rat, cat, dog, monkey




Stein, 1995 [34] Rat; human; cultured cells
Suri et al., 2007 [23] Human Human
Walsh et al., 2010 [24] Human Humanmodulation of connective tissue homeostasis and sex dif-
ferences in risk for osteoarthritis of the knee”).
It has also been suggested that opioid agonists can be
less potent and efficacious in females than males [28];
however, the data may depend on species, disease
process, and age [29,30]. For example, opioids appear to
be less efficacious in female rodents than males, whereas
opioids seem to be more efficacious in women than men
[30,31]. A recent review of the literature suggests that μ-
and μ/κ-mixed agonists are more effective in women,
particularly for morphine [32]. However, most studies
examine postoperative or emergency-room pain, mor-
phine, and short-duration usage. Meta-analysis of trials
of efficacy in people with osteoarthritis show a signifi-
cant reduction in pain and improved physical function
with moderate effect sizes [33]. Although opioids have
been shown to be efficacious in people with osteoarth-
ritis, it is unclear if there are sex differences in opioid ef-
ficacy in this population or with more long-term usage.
After injury, including OA, there is an upregulation of
endogenous opioid peptides in inflammatory cells at the
site of insult as well as an up-regulation of opioid recep-
tors on peripheral terminals of nociceptors innervating
the injured tissue [34]. In individuals with OA, this up-
regulation of opioid receptors and peptides increases
endogenous inhibition locally because intraarticular
blockade of opioid receptors with naloxone increases the
arthritic pain [34]. One possibility is that these changes
in opioids may be explained by the influence of sex hor-
mones on the peripheral expression and potency of en-
dogenous opioid peptides and their receptors. Thus, the
changes in endogenous inhibition, particularly the opioidFindings
Glutamate injected into masseter muscle produced greater nociceptor
excitation in female rats.
Mu-opioid agonists are more effective in male vs. female arthritic rats;
effects are both peripheral and central.
Compared ovariectomized with and without estrogen; Estrogen
increases nociceptor excitability of TMJ neurons in cells from
uninjured and inflamed rats.
Review discussing innervation of joint structures including
71 references. No mention of male or female in text.
Review discussing effects of cytokines on joint afferents including
55 references. No mention of male or female in text.
Shows neuropeptide innervation of hyaline cartilage and fibrocartilage.
Review article discussing peripheral opioid effects in arthritis including
50 references; no mention of sex differences.
Shows innervation of articular cartilage in subjects with OA;
no mention of sex differences.
Shows vascularization and innervation of RA and OA joints.
No mention of sex differences.
Table 3 Identified gaps in sex/gender differences in knee
OA
Gaps related to peripheral nervous system
Gap 1 Are there sex differences in nociceptor innervation
of the OA joint?
Gap 2 Do sex hormones modify knee joint nociceptor activity?
Gap 3 Do nociceptors innervating the OA joint respond
differently to inflammatory stimuli between the sexes?
Gap 4 Does peripheral opioid peptide and receptor upregulation
after knee OA differ between the sexes?
Gaps related to the central nervous system
Gap 5 Are there sex differences in processing of nociceptive
information from knee in the central nervous system
in the healthy or diseased knee?
Gap 6 Are there sex differences in brain activation patterns
associated with knee OA pain?
Gap 7 Do sex hormones modulate central neuronal activity
associated with nociception in the healthy or diseased knee?
Gap 8 Are there sex differences in OA patients for measures of
temporal summation (central excitability) and conditioned-pain
modulation (central inhibition)?
Gaps related to psychosocial factors
Gap 9 Are there sex differences in psychosocial variables in OA
such as depression, anxiety, self-efficacy, pain catastrophizing,
and fear of pain?
Gaps that encompass all factors
Gap 10 Are different pharmacologic and non-pharmacologic
strategies needed to address treatment of adverse
psychosocial variables between sexes?
Gap 11 Might effective pain management strategies to reduce
pain in OA differ between women and men?
Gap 12 What is the influence of age on sex differences?
Figure 3 Example of temporal summation in response to
pressure applied either to the knee joint or to the anterior
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women with OA than in men.
In summary, peripheral factors can contribute to pain
in knee OA (Table 2); however, little is known about sex
differences in these peripheral factors (Table 3). The
growth of new nociceptors, activation of nociceptors in
the subchondral bone exposed after cartilage degrad-
ation, and nociceptors innervating synovium sensitized
by inflammatory mediators could all augment the per-
ipheral input to the central nervous system and result in
pain. Increased nociceptor activation by noxious stimuli
and reduced inhibition in the periphery could also con-
tribute to the greater pain observed in women with OA.tibialis muscle at the pressure-pain threshold in people with
osteoarthritis. VAS scores were normalized for comparison by
subtracting the first stimulus pain score from subsequent pain
scores. Group A had more clinical pain with VAS scores of 6/10 or
greater and Group B had clinical pain scored less than 6/10. These
two groups were compared to age and sex-matched controls. The
greatest temporal summation occurred in the group with the
highest pain scores. *, p<0.05 Group A different from controls and
Group B; Group B different from Controls. Reprinted from [5] with
permission of the International Association for the Study of Pain.Pain is created by the central nervous system
The CNS creates and modulates the experience of pain
whether derived and maintained from nociceptive input
(e.g. knee arthritis) or maintained independent of noci-
ceptive input. Pain is a product of a dynamic balance
between facilitation and inhibition of information pro-
cessing. In people with chronic OA, there is increasedcentral excitability and decreased central inhibition [5].
Central excitability can be assessed by testing “temporal
summation,” which corresponds to a progressive increase
in reported pain in response to the same noxious stimu-
lus given repetitively. People with OA show augmented
temporal summation to noxious stimulation compared
with controls, and temporal summation among people
with osteoarthritis is greater in those with higher pain
than in those with lower pain (> 6 VAS vs. <6 VAS) [5]
(Figure 3). In addition, temporal summation significantly
correlates with other aspects of OA pain, such as pain
duration and pain during walking, suggesting central
excitability may underlie these pain measures as well
Sluka et al. Biology of Sex Differences 2012, 3:26 Page 7 of 12
http://www.bsd-journal.com/content/3/1/26[5]. Furthermore, infusion of hypertonic saline into the
tibialis anterior muscle in people with knee OA results
in greater areas of referred pain and longer lasting sensi-
tivity to noxious stimuli [35], and there are widespread
increases in sensitivity to noxious stimuli (secondary
hyperalgesia) among people with OA [36].
Conditioned pain modulation, also referred to as dif-
fuse noxious inhibitory controls (DNIC), is based on the
finding that some neurons in the spinal cord of rodents
are inhibited when a noxious stimulus is applied beyond
the excitatory receptive field of the neuron [37]. This ob-
servation presumably underlies the reduction in pain
experienced by humans in one area of the body when a
noxious stimulus is applied to another area. This type of
inhibitory control is reduced in people with OA [5,36],
but the depression of conditioned pain modulation
returns to normal after total joint replacement in
patients who are pain-free [36]. It is unclear if those who
have pain after TKA have reduced conditioned pain
modulation, as occurs in other postoperative conditions
[38]. Thus, people with OA have both altered central ex-
citability and altered central inhibition (Figure 1).
Central processing appears to differ between the sexes.
For example, there is greater temporal summation to
both heat and mechanical stimuli in healthy women
compared with men [39], suggesting enhanced central
excitability. Healthy men show a greater decrease in
temporal summation and increase in pain thresholds in
response to conditioned pain stimulation when com-
pared with women [40,41], suggesting that women have
less effective central inhibition than men. Together,
these data indicate that the normal state for women is a
greater ability to produce central sensitization to periph-
eral stimuli and less effective inhibitory systems, but
there is evidence that central inhibitory mechanisms
vary with the menstrual cycle, which may temper these
conclusions [42]. Overall, little is known about sex dif-
ferences in central excitability and central inhibition in
people with OA.
Brain imaging studies have shown that multiple cortical
and subcortical sites in the brain are engaged when an
individual experiences pain. When data are collapsed
across subjects, the sites whose components are activated
most consistently are referred to as the “pain matrix,” al-
though there are individual differences and areas outside
this matrix can be involved (e.g., cerebellum). Classical
somatosensory regions, including the somatosensory
cortex, thalamus, and spinal cord, that are activated by
noxious stimuli likely mediate the sensory component of
nociception (i.e., recognition of injury). In addition, the
anterior cingulate cortex, insular cortex, amygdala, and
prefrontal cortex are also activated when an individual
experiences pain. These regions may contribute to the
emotional aspect of the pain experience, includingunpleasantness and fear as well as the associated anxiety
and depression.
In patients with OA, painful mechanical knee stimula-
tion is associated with enhanced brain activity in the
thalamus, somatosensory cortex, cingulate cortex, and
amygdala [43,44]. Brain activity decreases after the appli-
cation of intra-articular lidocaine to the osteoarthritic
knee, and changes in the thalamus correlate with changes
in pain ratings [43]. When patients with OA are com-
pared with healthy controls, spontaneous pain of OA
activates the prefrontal limbic regions, and this pain and
activity is reduced by a cyclooxygenatase-2 inhibitor [45],
suggesting these regions are critical for spontaneous
pain. Furthermore, there is a reduction in gray matter
volume of the thalamus in people with hip OA that is
reversed at 9 months after total hip replacement [46];
however the clinical significance of reduced gray matter
volume is unclear. The activation of the pain matrix and
the reduction in gray volume have been observed in mul-
tiple pain conditions [47]. Thus, OA-associated changes
in components of the pain matrix and perhaps other
regions are modifiable with effective treatments.
Subcortical sites activated during pain include areas in
the brainstem, such as the periaqueductal gray (PAG)
and the rostral ventromedial medulla (RVM). A key con-
nective pathway appears be from the PAG to the RVM
and thence to the spinal cord to inhibit activity of noci-
ceptive spinal neurons and thereby reduce central
sensitization; this pathway is critical in opioid analgesia.
The PAG-RVM-spinal cord pathway contains endogen-
ous opioid peptides and receptors, and when activated
reduces central sensitization and hyperalgesia through
activation of opioid peptides. Neurons in this pathway
can also elicit the converse modulation and increase
excitability of nociceptors to enhance pain, thereby
providing a supraspinal mechanism for pain facilitation.
Brain imaging studies in people with OA show greater
activation of this facilitatory pathway in response to nox-
ious stimulation in referred pain areas [48], a measure of
secondary hyperalgesia. Because activity in these brain-
stem sites correlates with measures of centrally-mediated
pain symptoms in people with OA [48], subcortical acti-
vation in the PAG and RVM may predict central
sensitization. Accordingly, hyperalgesia is reversed by
blockade of neural activity in the RVM or the PAG in
animal models of musculoskeletal pain [49].
Sex differences in these subcortical brain sites may
help explain differences in opioid analgesic potency and
efficacy between male and female rodents [28]. For ex-
ample, male rats express more mu-opioid receptors in
the PAG that correlate positively with the difference in
morphine analgesia [28] supporting the fact that that
males require less morphine than females. Female rats
have a greater number of neurons that project from the
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vated by tissue injury [28], suggesting that females do
not activate inhibitory pathways to the same extent as
males. These data indicate that subcortical brainstem
sites are key modulators of nociception and that differ-
ential expression of sex-steroid receptors may alter noci-
ceptive processing.
In this context, sex differences in opioid analgesia are
a topic of considerable interest both experimentally and
clinically. Initial findings led to the conclusion that
whereas opioid analgesia was greater in female rodents
than males, the opposite was the case in humans
reviewed in [50]. Since then, however, it has become
clear that the situation is not straightforward; conclu-
sions seem premature because so many different genetic,
physiological, hormonal, pharmacologic, and psycho-
social factors contribute to sex differences in opioid an-
algesia in both animal models and humans [30,51-54].
Within the spinal cord, sex differences also occur in
the processing of nociceptive information. As an ex-
ample, male mice that do not express a functional Toll-
like receptor 4 (TLR4) do not develop pain-behaviors
after either nerve injury or inflammation, blockade of
TLR4 in the spinal cord reduces pain- behaviors in mice,Table 4 Central mechanisms of knee OA
Study Male Female Findings
Arendt-Nielsen et al., 2010 [5] Human Human Increased central excitabi
correlation between radio
Arendt-Nielsen et al., 2008 [41] Human Human Healthy men show greate
modulation.
Bajaj et al., 2001 [35] Human Human Hypertonic saline infusion
of sex differences.
Baliki et al., 2008 [43] Human Human fMRI shows enhanced ac
in OA patients in respons
to intra-articular lidocaine
Ge et al., 2005 [61] Human Human Reduced pain ratings to a
women.
Bwilym et al., 2010 [46] Human Human Imaging study shows tha
sex differences reported.
Gwilym et al., 2009 [48] Human Human Imaging study shows pat
that is correlated with ne
Kulkarni et al., 2007 [44] Human Human Reduction in conditioned
pain-free individuals; no s
LeBars et al., 1979 [37] Rat Activation of diffuse noxi
in spinal cord.
Loyd and Murphy, 2006 [62] Rat Rat Review article including 1
Parks et al., 2011 [45] Human Human fMRI in knee OA shows s
decreases spontaneous p
Sarlani and Greenspan, 2002
[39]
Human Human Greater temporal summa
Staud et al., 2003 [40] Human Human Conditioned pain modula
Tousignant-Laflamme and
Marchand, 2009 [42]
Human Menstrual cycle alters con
Yarnitsky et al., 2008 [38] Human Human Lower conditioned pain mand activation of TLR4 in the spinal cord produce pain-
behaviors. These effects do not occur in female mice as
they still exhibit pain behaviors without a functional
TLR4 receptor, TLR4 antagonists have no effect on pain-
behaviors, and TLR4 activation has no effect [55]. The
TLR4 effect on pain behaviors in males is dependent on
testosterone [55]. Moreover, females exhibit greater sen-
sitivity of nociceptive dorsal horn neurons to noxious
visceral stimulation than males that depends on estrogen
and is associated with greater spinal expression of exci-
tatory neurotransmitter receptors (GluN1) [56,57]. Also,
morphine acts via μ- and κ-opioid receptors in the spinal
cord of females but only via μ-opioid receptors in males
[51,58]. This sex difference is due to a difference in the
molecular structure of opioid receptors in the spinal
cord showing a greater prevalence of a mu-opioid and
kappa-opioid receptor heterodimers that changes across
the estrous cycle [51]. Thus, structural and molecular
changes can differ between the sexes that may explain
some of the underlying differences in pain sensitivity.
However, how these relate to the nociceptive transmis-
sion from the joint or in osteoarthritis is unknown.
In summary, central nervous system factors contribute
to pain in knee OA (Table 4). The enhanced centrallity in OA subjects; greater excitability with greater OA pain; lack of
graphic findings and pain; no discussion of sex differences.
r decrease in central excitability in response to conditioned pain
into tibialis anterior shows greater areas of referred pain; no discussion
tivity in thalamus, somatosensory cortex, cingluate cortex, and amygdala
e to painful mechanical stimulation; decreased brain activity in response
.
second intramuscular injection of glutamate in men compared to
t atrophy of thalamus in hip OA is reversed by total hip replacement; no
ients with OA have increased activity in brainstem facilitation pathway
uropathic symptoms; no sex differences reported.
pain modulation in OA, that is reversed after total joint replacement in
ex differences reported.
ous inhibitory control pathways reduces activity of nociceptive neurons
41 references describing sex differences in central pain modulation.
pontaneous pain activates prefrontal-limbic regions; COX-2 inhibitor
ain and activity in prefrontal-limbic regions; no sex differences reported.
tion to heat and mechanical stimuli in healthy women than men.
tion is more effective in heathy men than women.
ditioned pain modulation in healthy women.
odulation prior to surgery is predictive of postoperative chronic pain.
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could lead to prolonged and greater pain that does not
directly match the degree of injury. Differences in pro-
cessing of nociceptive information in supraspinal brain
sites could explain the differences observed between
men and women with osteoarthritis; however, these
studies have yet to be done (Table 3). Despite the data
on sex differences in processing of painful stimuli at
multiple central nervous system sites [59,60], there are
virtually no data on sex differences that occur after
stimulation of joint tissue, after injury to a joint, or in
osteoarthritis.
Psychosocial factors that influence pain
Pain is a multidimensional experience that includes psy-
chological, emotional, environmental, and social factors.
Literature on environmental and social factors related to
sex differences in OA pain is limited, although there is a
growing literature on social factors related to knee OA
surgery [15,63,64]. This section of the review focuses on
psychological and emotional factors. There is a wide
variation in how people cope with pain, how they think,
interpret and report pain, as well as psychosocial and en-
vironmental factors that can influence pain. These con-
structs can influence the experience of pain in both
positive and negative ways [65]. For example, pessimistic
patients have more moderate-to-severe pain than non-
pessimistic patients two years after total knee replace-
ment surgery [2]. Individuals with chronic pain use a
mixture of active coping strategies (distraction, modify-
ing activity) as well as passive coping strategies (resting,
ignoring the pain). Those who rely on passive strategies
are more likely to have greater pain and reduced func-
tion [66]. Environmental factors, such as social support
can influence the timing and recovery from total knee
arthroplasty [63], but does not appear to differ between
the sexes [15]. It is possible that some of these coping
strategies and psychosocial factors can differ between
men and women. Through education and exercise, cop-
ing strategies can become active and thereby improve
psychosocial factors such as depression, anxiety, pain
catastrophizing, self-efficacy, and fatigue.
The way an individual thinks about and interprets pain
explains some of the variability in pain among indivi-
duals, and is particularly relevant to sex differences in
pain [67]. Men tend to be more stoic, under-report pain,
and endure more pain because of social and cultural
norms. In contrast, women are more alert to the poten-
tial danger of injury, tend to experience pain with
greater emotion, worry more about the consequences of
pain, seek more treatment for it, and have higher use of
prescription and over-the-counter medications [67].
Women tend to use a greater repertoire of coping strat-
egies, such as seeking social support, relaxation anddistraction, and active behavioral and cognitive coping
mechanisms [67]. In contrast, men tend to rely more on
more focused approaches, such as problem solving, de-
nial, optimism, and tension-reducing activities, such as
alcohol consumption [67]. Understanding the differences
in the way men and women process, discuss, and cope
with pain can inform effective treatment programs.
Two constructs that have emerged as strong predictors
of pain and therapeutic outcomes in a variety of pain
conditions are pain catastrophizing and self-efficacy.
Pain catastrophizing reflects the tendency to focus and
magnify the consequences of the pain and to feel help-
less in managing the pain. Self-efficacy is the belief that
one can achieve a desirable outcome, such as pain relief
or improve activities of daily living. Higher catastrophiz-
ing scores are associated with greater pain and disability
6 weeks after total knee replacement [14], poor outcome
6 months after total knee replacement [68], and contrib-
ute to reduced function in late stage knee OA [15].
However, higher pain catastrophizing was not related to
pain during movement or physical activity levels in a
sample of 208 people with late-stage knee OA [15].
Higher self-efficacy scores in pain and functional activ-
ities directly correlate with less pain and greater func-
tion, respectively [69]. Further, self-efficacy beliefs for
pain underlie the relation between pain catastrophizing
and pain [70]. Therapeutic strategies that increase self-
efficacy can reduce catastrophizing and improve pain
and function. For example, self-management strategies
(such as exercise and activity management) can improve
self-efficacy and pain catastrophizing, and have been
shown to reduce pain and improve function in people
with OA [19]. Similarly, behavioral interventions just
prior to surgery improved self-efficacy, decreased pain,
and improved function [16]. A recent study showed no
difference between men and women in pain catastrophiz-
ing in people with late stage OA [15]. Although catastro-
phizing can influence such sex differences in pain-related
outcomes as pain intensity and disability, it is unknown
whether women undergoing TKA are more likely to cata-
strophize than men.
Another construct that is highly associated with pain
and function in OA is fear of pain. Fear of pain refers to
an excessive expectation that physical activity will
worsen pain and function. People with pain-related fear
are likely to avoid physical activity, which decreases
function and increases disability. Maintaining physical
activity and exercise are critical self-management skills
that are effective for reducing pain and improving func-
tion in people with OA [71]. Pain-related fear explains
significant amounts of variance in physical disability
(25%), pain (13%), and function (1%) [72]. At present, it
is not known whether pain-related fear contributes to
sex differences in OA pain and function.
Table 5 Psychosocial variables in knee OA
Study Findings
Dekker et al., 2009
[17]
People with OA have a higher prevalence of depression and anxiety and this is associated with worse pain and greater
healthcare utilization; sex differences not reported.
Fransen et al., 2002
[71]
Systematic review showing exercise reduces pain and improves function in OA; sex differences not reported.
Lamb et al., 2008
[16]
Behavioral interventions prior to surgery improve self-efficacy, decrease pain, and improve function in OA; sex differences not
reported.
Lorig et al., 2008
[19]
Self-management strategies improve self-efficacy and pain catastrophizing in OA; sex differences not reported.
Marks et al., 2009
[18]
People with depression have reduced function and recover slower after total joint replacement; sex differences not reported.
Pells et al., 2008 [69] Higher self-efficacy scores in pain and function correlate with lower pain and greater function in OA; sex differences not
reported.
Perrot et al., 2008
[66]
Passive coping strategies generally result in higher pain and lower function; sex differences not reported.
Riddle et al., 2010
[68]
Higher catastrophizing scores are associated with poor outcome 6 months after total knee replacement; sex differences not
reported.
Shelby et al., 2008
[70]
Self-efficacy beliefs underlie the relation between pain catastrophizing and pain; sex differences not reported.
Singh et al., 2008 [2] Pessimistic patients have more moderate-to-severe pain 2 years after total knee replacement; sex differences not reported.
Somers et al., 2009
[72]
Pain-related fear explains part of the variance in physical disability, pain, and function in OA; sex differences not reported.
Sullivan et al., 2009
[14]
Higher pain catastrophizing scores are associated with greater pain and disability 6 weeks after total joint replacement; sex
differences not reported.
Tonelli et al., 2011
[15]
Shows greater pain during movement in women with late stage OA; no difference in depression, anxiety or pain
catastrophizing between sexes in OA; models predictors of movement pain in women and men with OA.
Tsai, 2007 [73] Depression tendency in OA explain a portion of the sex differences in pain.
Unruh, 1996 [67] Review discussing sex differences in the clinical pain experience.
All studies were performed in human subjects and included both men and women.
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ciated with OA. People with OA have a higher incidence
of depression and anxiety than the general population
and are associated with greater pain intensity, worse
symptoms, greater healthcare utilization, and report
more pain after total joint replacement [17]. In addition,
people with depression have lower functional scores and
slower recovery after total joint replacement [18]. One
study found that depression scores in Chinese elders with
OA explained a portion of the sex differences in pain
[73], but the general pain literature does not support the
conclusion that depression is an explanatory factor [74].
However, how anxiety and depression contribute to sex
differences in pain and function among people with OA
is unknown.
In summary, psychosocial variables contribute to pain
variability (Table 5). No single factor is likely to explain
all of the sex differences in pain [20], including pain
experienced by individuals with OA. Although some
investigators have begun to examine the interactions
among multiple psychosocial variables in people with
OA, there are few such data particularly related to sex
differences (Table 3). Pain catastrophizing and self-
efficacy contribute to the pain and functional deficitsassociated with OA, but little is known about their inter-
action with such factors as depression and anxiety.
Similarly, little is known about the influence of envir-
onmental and social factors. Treatment strategies based
on the psychosocial profile of an individual and pos-
sible sex differences need to be developed to improve
pain outcomes.
Conclusion
Pain in knee OA involves the peripheral and central
nervous system whose processing is influenced by psy-
chosocial variables. Sex differences exist, but our
understanding of them is rudimentary. Persistent pain
that continues after knee replacement surgery has healed
occurs more in women than men. We have identified
gaps in the literature as they relate to sex differences in
OA pain (Table 3). These gaps focus on understanding
sex differences in common factors thought to be asso-
ciated with OA pain, including nociceptor innervation
and sensitization, central nociceptive processing and
sensitization, effects of sex hormones on neuron activa-
tion, and differences in psychosocial variables and coping
strategies. One of the major gaps in the literature on
osteoarthritis and pain is the differences between pre-
Sluka et al. Biology of Sex Differences 2012, 3:26 Page 11 of 12
http://www.bsd-journal.com/content/3/1/26and post-menopausal women. Research to improve
understanding of chronic pain and the influence of sex
and gender issues is essential to develop effective inter-
ventions to decrease pain and improve quality of life.
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